Ospemifene

奥培米芬

Report date: 2022/08/12 14:21:11
NME

Base Information

Drug NameOspemifene
Drug Alias Nameospemifeno欧司哌米芬ospemifenumOphenaOsphena +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEstrogen receptors modulators
TargetsEstrogen receptors
Therapy Area/IndicationsVulvar and vaginal atrophyAtrophyVaginal Diseases +[4] 
Global Approved IndicationsVulvar and vaginal atrophyDyspareunia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2013/02/26
Country/TerritoryUnited StatesUnited KingdomEU +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShionogi & Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDuchesnay IncShionogi BvNanjing Huawe Medicine Technology Group Co Ltd
Inactive CompaniesHormos MedicalShionogi & Co Ltd
Active IndicationsVulvar and vaginal atrophyDyspareunia
Inactive IndicationsAtrophyVaginal Diseases

Other Information

ATC CodeG03XC05
Related LinksWikipediaDrugBankKEGG